MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 55, Issue 5, Pages 768-777
Publisher
Wiley
Online
2015-04-07
DOI
10.1002/mc.22320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Down-regulation of miRNA-452 is Associated with Adriamycin-resistance in Breast Cancer Cells
- (2014) Qing Hu et al. Asian Pacific Journal of Cancer Prevention
- The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin
- (2014) Brian Ell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer
- (2014) Jun Wang et al. Molecular Oncology
- A systematic review of microRNA expression profiling studies in human gastric cancer
- (2014) Sirjana Shrestha et al. Cancer Medicine
- Different miRNA expression profiles between human breast cancer tumors and serum
- (2014) Jie Zhu et al. Frontiers in Genetics
- Decreased levels of circulating and tissue miR-107 in human esophageal cancer
- (2013) Priyanka Sharma et al. BIOMARKERS
- Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model
- (2013) P Rotkrua et al. BRITISH JOURNAL OF CANCER
- Upregulation of MicroRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1
- (2013) Fan Li et al. FEBS LETTERS
- miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4
- (2012) H.-Y. Chen et al. CANCER RESEARCH
- Lipid-based Nanoparticle Delivery of Pre-miR-107 Inhibits the Tumorigenicity of Head and Neck Squamous Cell Carcinoma
- (2012) Longzhu Piao et al. MOLECULAR THERAPY
- P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2
- (2012) Lei Chen et al. NEUROSCIENCE LETTERS
- Loss of p53 and Acquisition of Angiogenic MicroRNA Profile Are Insufficient to Facilitate Progression of Bladder Urothelial Carcinomain Situto Invasive Carcinoma
- (2011) Francisco Ayala de la Peña et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans
- (2011) Pai-Sheng Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ
- (2011) J Datta et al. ONCOGENE
- The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasis
- (2011) Manav Korpal et al. RNA Biology
- Dysregulation of the Mitogen Granulin in Human Cancer through the miR-15/107 microRNA Gene Group
- (2010) W.-X. Wang et al. CANCER RESEARCH
- Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
- (2009) Yanping Lin et al. BMC CANCER
- SIAH1 induced apoptosis by activation of the JNK pathway and inhibited invasion by inactivation of the ERK pathway in breast cancer cells
- (2009) Yuan-Yuan Wen et al. CANCER SCIENCE
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started